Ncnpc header
Ncnpc avatar 256x256
Northern Colorado Nurse Practitioner Coalition

Stakeholder Input Needed on Opioid Guidelines

Posted 12 days ago by Laura Hildebrand

Stakeholder Input Needed on Opioid Guidelines

Greetings from the Division of Professions and Occupations:

We are writing to solicit feedback on proposed changes to the  Guidelines for Prescribing and Dispensing Opioids (Guidelines) following the September 2018 stakeholder meeting where the proposed changes were discussed.  The proposed changes include adding additional information to the appendix and addressing the new requirements in Senate Bill 18-22 Clinical Practice for Opioid Prescribing. This new state law went into effect on May 21, 2018, immediately upon the Governor’s signature.  The law sets forth prescribing requirements, such as the number of opioids to be prescribed and required Prescription Drug Monitoring Program checks in certain clinical situations. The law also provides specific exemptions to these requirements.

The Guidelines were previously revised and released to the public in April 2018. The prescribing Boards under the Division’s auspices remain committed to ensuring that the document serves as a consistent reference that reflects best practices for stakeholders and any new laws the Boards must implement and enforce. To that end, the Division of Professions and Occupations is requesting public feedback in order to fully review any impacts the most recent proposed changes may have on consumer protection.

Final changes to the Guidelines will require formal adoption by the Colorado Dental Board, the Colorado Medical Board, the State Board of Nursing, the State Board of Optometry,  the Colorado Podiatry Board, and the State Board of Pharmacy, and an endorsement by the State Board of Veterinary Medicine.

If you have questions or would like to provide written comments on the proposed changes, please send them to Holli Weaver at by December 15, 2018, at 5:00 p.m.

Additional information on the Guidelines is available on the Division’s website.


Do not reply to this email – this is not a monitored inbox